Form D · Pharmaceuticals

BioNumerik Pharmaceuticals, Inc.

San Antonio, TX · CIK 0000895131

Offering snapshot reported Nov 8, 2012 · SEC filing

Reported sold: $10.2M
Investors reported: 3
Minimum accepted: $25K
First sale: Oct 24, 2012

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Nov 8, 2012	Initial	$10,190,500	No comparison	3	SEC filing
Nov 12, 2010	Initial	$1,130,000	No comparison	4	SEC filing
Mar 13, 2009	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Equity, Option to acquire, Security to be acquired
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-186708

Total Offering Amount and Total Remaining to be Sold includes $6,875,846 potential proceeds from the exercise of warrants issued or to be issued as part of the transaction.

Source: Form D, filed Nov 8, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Stacey Bain	Executive
Steve Carchedi	Director
Frederick H. Hausheer	Director, Executive
Harry R. Jacobson	Director
Harry Kochat	Executive
James R. Leininger	Director
David R. Margrave	Executive
Homer L. Pearce	Director
Dennert O. Ware	Director
John W. Yarbro	Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

8122 Datapoint Drive Suite 1250
San Antonio, TX, 78229